endolymphatic sac tumor
endolymphatic sac tumor
Explore linked clinical trials. Standard reference: MONDO:00061901 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomatosis, benign urinary system neoplasm, capillary hemangioma, carcinoma, cardiovascular disorder, endolymphatic sac tumor, epithelial neoplasm, hemangioblastoma, hemangioma, hereditary disease, kidney cancer, kidney disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neuroendocrine neoplasm, neuroepithelial neoplasm, paraganglioma, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, renal cell carcinoma, urinary system disorder, vascular cancer, vascular disorder, von Hippel-Lindau disease | Recruiting | Phase 2 | 2025-09-11 | NCT07167329 |